Down syndrome and genetics - A case of linked histories

Nature Reviews Genetics

Volumn 6, Issue 2, 2005, Pages 137-147

  Patterson, David ^a,b   Costa, Alberto C S ^a,b  

^a UNIVERSITY OF DENVER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEOME; TRANSCRIPTOME;

ANIMAL MODEL; CHROMOSOME DISORDER; DOWN SYNDROME; EVOLUTION; GENE MAPPING; GENETIC LINKAGE; GENETIC MODEL; GENETICS; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HYBRID CELL; INTELLECTUAL IMPAIRMENT; LINKAGE ANALYSIS; MOUSE STRAIN; NONHUMAN; PHENOTYPE; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIORITY JOURNAL; RADIATION HYBRID MAPPING; REVIEW; SOMATIC CELL HYBRID MAPPING; TRANSGENIC MOUSE; TRISOMY 21;

ANIMALS; CHROMOSOMES, HUMAN, PAIR 21; DOWN SYNDROME; FEMALE; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MICE; PREGNANCY; PRENATAL DIAGNOSIS;

ANIMALIA; MUS MUSCULUS;

EID: 13144260659     PISSN: 14710056     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrg1525     Document Type: Review

References (148)

1. Roizen, N. J. & Patterson, D. Down's syndrome. Lancet 361, 1281-1289 (2003).
2. Lejeune, J. Le mongolism: premier exemple d'aberration autosomique humaine. Ann. Genet. 1, 41-49 (1959) (in French).
3. Friedman, J. M. Racial disparities in median age at death of persons with Down syndrome - United States, 1968-1997. MMWR Morb. Mortal Weekly Rep. 50, 463-465 (2001).
4. Bittles, A. H. & Glasson, E. J. Clinical, Social, and ethical implications of changing life expectancy in Down syndrome. Dev. Med. Child Neurol. 46, 282-285 (2004).
5. Cohen, W. I. in Down Syndrome: a Promising Future Together (eds Hassold, T. J. & Patterson, D.) 15-36 (Wiley-Liss, New York, 1999).
6. Tolmie, J. L. in Emery and Rimoin's Principles and Practices of Medical Genetics (eds Rimoin, D. L. et al.) 1129-1183 (Churchill Livingstone, London; New York, 2002).
7. Darwin, C. The Origin of Species (John Murray, London, 1859).
8. Darwin, C. The Descent of Man and Selection in Relation to Sex (John Murray, London, 1871).
9. Mendel, G. Versuche über Pflanzen-Hybriden. Verhand. naturfors. Vereines in Brunn 4, 3-47 (1865) (in German); English translation available online at 〈http://www. mendelweb.org/Mendel.html〉.
10. Down, J. L. H. Observations on an ethnic classification of idiots. Lond. Hosp. Rep. 3, 259-262 (1866); reprinted in Ment. Retard. 33, 54-56 (1995).
11. Down, J. L. H. Observations on an ethnic classification of idiots. Lond. Hosp. Rep. 3, 259-262 (1866); reprinted in Ment. Retard. 33, 54-56 (1995).
12. Ward, O. C. John Langdon Down, 1823-1896: a Caring Pioneer (Eponymists in Medicine) (R. Soc. Med. Press, London, 1998).
13. Shuttleworth, G. E. Mongolian imbecility. BMJ 2, 661-665 (1909).
14. Fraser, M. & Mitchell, A. Kalmyc idiocy. J. Ment. Sci. 22, 169-179 (1876).
15. Alzheimer, A., Stelzmann, R. A., Schnitzlein, H. N. & Murtagh, F. R. An English translation of Alzheimer's 1907 paper, "Über eine eigenartige Erkankung der Hirnrinde". Clin Anat. 8, 429-431 (1995).
16. Jervis, G. A. Early senile dementia in mongoloid idiocy. Am. J. Psychiatry 105, 102-106 (1948).
17. Allen, G. et al. "Mongolism". Lancet 1, 775 (1961).
18. Howard-Jones, N. On the diagnostic term "Down's disease". Med. Hist. 23, 102-104 (1979).
19. Flemming, W. Beitrage zur kenntnis der zelle und ihrer Lebenserscheinungen, Thiel II. Archiv. Mikroskopische Anatomie 18, 151-259 (1880) (in German); English translation available in J. Cell Biol. 25, 3-69 (1965).
20. Flemming, W. Beitrage zur kenntnis der zelle und ihrer Lebenserscheinungen, Thiel II. Archiv. Mikroskopische Anatomie 18, 151-259 (1880) (in German); English translation available in J. Cell Biol. 25, 3-69 (1965).
21. Sutton, W. S. The chromosomes in heredity. Biol. Bull. 4, 231-251 (1903).
22. Morgan, T. H., Sturtevant, A. H., Muller, H. J. & Bridges, C. B. The Mechanism of Mendelian Heredity (Constable Press, London, 1915).
23. Painter, T. The Y-chromosome in mammals. Science 53, 503-504 (1921).
24. Painter, T. Studies in mammalian spermatogenesis. II. The spermatogenesis of man. J. Exp. Zool. 37, 291-336 (1923).
25. Davenport, C. B. in Sixth International Congress of Genetics Vol. 1. (ed. Jones, D. F.) 135-140 (Brooklyn Botanic Garden, New York, 1932).
26. Waardenburg, P. J. Das Menschliche Auge und seine Erbanlagen (Martinus Nijhoff, The Hague, 1932) (in German).
27. Tjio, J. H. & Levan, A. The chromosome number of man. Hereditas 42, 1-6 (1956).
28. Kodani, M. Three chromosome numbers in whites and Japanese. Science 127, 1339-1340 (1958).
29. Tjio, J. H. & Puck, T. T. Genetics of somatic mammalian cells. II. Chromosomal constitution of cells in tissue culture. J. Exp. Med. 108, 259-268 (1958).
30. Jacobs, P. A., Baikie, A. G. Court-Brown, W. M. & Strong, J. A. The somatic chromosomes in mongolism. Lancet 1, 710 (1959).
31. Polani, P. E. et al. A mongol girl with 46 chromosomes. Lancet 1, 313-324 (1960).
32. Carter, C. O., Hamerton, J. L., Polani, P. E., Gunalp, E. & Weller, S. D. Chromosome translocation as a cause of familial mongolism. Lancet 2, 678-680 (1960).
33. Clarke, C. M., Edwards, J. H. & Smallpiece, V. 21-trisomy/normal mosaicism in an intelligent child with some Mongoloid characters. Lancet 18, 1028-1030 (1961).
34. Caspersson, T., Zech, L., Johansson, C. & Modest, E. J. Identification of human chromosomes by DNA-binding fluorescent agents. Chromosoma 30, 215-227 (1970).
35. Caspersson, T., Hultén, M., Lindsten, J. & Zech, L. Distinction between extra G-like chromosomes by quinacrine mustard fluorescence analysis. Exp. Cell Res. 63, 240-243 (1970).
36. Aula, P., Leisti, J. & von Koskull, H. Partial trisomy 21. Clin. Genet. 4, 241-251 (1973).
37. Niebuhr, E. Down's syndrome: the possibility of a pathogenetic segment on chromosome no. 21. Humangenetik 21, 99-101 (1974).
38. Korenberg, J. R. et al. Molecular definition of a region of chromosome 21 that causes features of the Down syndrome phenotype. Am. J. Hum. Genet. 47, 236-246 (1990).
39. Delabar, J.-M. et al. Molecular mapping of twenty-four features of Down syndrome on chromosome 21. Eur. J. Hum. Genet. 1, 114-124 (1993).
40. Korenberg, J. R. et al. Down syndrome phenotypes: the consequences of chromosomal imbalance. Proc. Natl Acad. Sci. USA 91, 4997-5001 (1994).
41. Barlow, G. M. et al. Down syndrome congenital heart disease: a narrowed region and a candidate gene. Genet. Med. 3, 91-101 (2001).
42. Shapiro, B. L. Down syndrome - a disruption of homeostasis. Am. J. Med. Genet. 14, 241-269 (1983).
43. Pritchard, M. A. & Kola, I. The 'gene dosage effect' hypothesis versus the 'amplified developmental instability' hypothesis in Down syndrome. J. Neural Transm. 57, 293-303 (1999).
44. St George-Hyslop, P. H. et al. The genetic defect causing familial Alzheimer's disease maps on chromosome 21. Science 235, 885-890 (1997).
45. Goate, A. et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349, 704-706 (1991).
46. Hasle, H. Pattern of malignant disorders in individuals with Down's syndrome. Lancet Oncol. 2, 429-436 (2001).
47. Bacino, C. A. et al. Clinical and molecular studies in full trisomy 22: further delineation of the phenotype and review of the literature. Am. J. Med. Genet. 56, 359-365 (1995).
48. Tan, Y. H., Tischfield, J. & Ruddle, F. H. The linkage of genes for the human interferon-induced antiviral protein and indophenol oxidase-B traits to chromosome G-21. J. Exp. Med. 137, 317-330 (1973).
49. Moore, E. M., Jones, C., Kao, F.-T. & Oates, D. C. Synteny between glycinamide ribonucleotide synthetase and superoxide dismutase (soluble). Am. J. Hum. Genet. 29, 389-396 (1977).
50. Cox, D. R. & Shimizu, N. Report of the committee on the genetic constitution of chromosome 21. Cytogenet. Cell Genet. 55, 235-244 (1990).
51. Graw, S. L. et al. Molecular analysis and breakpoint definition of a set of human chromosome 21 somatic cell hybrids. Somat. Cell Mol. Genet. 21, 415-428 (1995).
52. Gardiner, K. et al. YAC analysis and minimal tiling path construction for chromosome 21q. Somat. Cell Mol. Genet. 21, 399-414 (1995).
53. Goss S. J. & Harris H. New method for mapping genes in human chromosomes. Nature 255, 680-684 (1975).
54. Cox, D. R., Burmeister, M., Price, E. R., Kim, S. & Myers, R. M. Radiation hybrid mapping: a somatic cell genetic method for constructing high-resolution maps of mammalian chromosomes. Science 259, 245-250 (1990).
55. Lynn, A. et al. Patterns of meiotic recombination on the long arm of human chromosome 21. Genome Res. 10, 1319-1332 (2000).
56. Hassold, T. & Sherman, S. Down syndrome: genetic recombination and the origin of the extra chromosome 21. Clin. Genet. 57, 95-100 (2000).
57. Cheung, V. G. et al. Integration of cytogenetic landmarks into the draft sequence of the human genome. Nature 409, 953-958 (2001).
58. Schwartz, D. C. & Cantor, C. R. Separation of yeast chromosome-sized DNA's by pulsed field gradient gel electrophoresis. Cell 37, 67-75 (1984).
59. Gardiner, K., Laas, W. & Patterson, D. Fractionation of large mammalian DNA restriction fragments using vertical pulsed-field gradient gel electrophoresis. Somat. Cell Mol. Genet. 12, 185-195 (1986).
60. Burke D. T., Carle, G. F. & Olson, M. V. Cloning of large segments of exogenous DNA into yeast by mean artificial chromosome vector. Science 236, 806-812 (1987).
61. Gardiner, K. et al. Analysis of human chromosome 21: correlation of physical and cytogenetic maps; gene and CpG island distributions. EMBO J. 9, 25-34 (1990).
62. Chumakov, I. et al. Continuum of overlapping clones spanning the entire human chromosome 21q. Nature 359, 380-386 (1992).
63. Ichikawa, H. et al. Long-distance restriction mapping of the proximal long arm of human chromosome 21 with Not I linking clones. Proc. Natl Acad. Sci. USA 89, 23-27 (1992).
64. Shizuya, H. et al. Cloning and stable maintenance of 300-kilobase-pair fragments of human DNA in Escherichia coli using an F-factor-based vector. Proc. Natl Acad. Sci. USA 89, 8794-8797 (1992).
65. Wang, D., Fang, H., Cantor, C. R. & Smith, C. L. A contiguous Not I restriction map of band q22.3 of human chromosome 21. Proc. Natl Acad. Sci. USA 89, 3222-3226 (1992).
66. Shepherd, N. S. et al. Preparation and screening of an arrayed human genomic library generated with the P1 cloning system. Proc. Natl Acad. Sci. USA 91, 2629-2633 (1994).
67. Korenberg, J. R. et al. A high-fidelity physical map of human chromosome 21q in yeast artificial chromosomes. Genome Res. 5, 427-443 (1995).
68. Patterson, D. & Sakaki, Y. The international consortium to sequence human chromosome 21. Genome Digest 4, 9-10 (1997).
69. Hattori, M. et al. The DNA sequence of human chromosome 21. Nature 405, 311-319 (2000).
70. Yamada, Y. et al. A comprehensive analysis of allelic methyiation status of CpG islands on human chromosome 21q. Genome Res. 14, 247-266 (2004).
71. Kampa D. et al. Novel RNAs identified from an in-depth analysis of the transcriptome of human chromosomes 21 and 22. Genome Res. 14, 331-342 (2004).
72. Waterston, R. H. et al. Initial sequencing and comparative analysis of the mouse genome. Nature 420, 520-562 (2002).
73. Gardiner, K., Fortna, A., Bechtel, L. & Davisson, M. T. Mouse models of Down syndrome: how useful can they be: comparison of the gene content of human chromosome 21 with orthologous mouse genomic regions. Gene 318, 137-147 (2003).
74. Patil, N. et al. Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21. Science 294, 1719-1723 (2001).
75. Mao, R., Zielke, C. L., Zielke, H. R. & Pevsner, J. Global up-regulation of chromosome 21 gene expression in the developing Down syndrome brain. Genomics 81, 457-467 (2003).
76. FitzPatrick, D. R. et al. Transcriptome analysis of human autosomal trisomy. Hum. Mol. Genet. 11, 3249-3256 (2002).
77. Reymond, A. et al. Human chromosome 21 gene expression atlas in the mouse. Nature 420, 582-586 (2002).
78. Gitton, Y. et al. A gene expression map of human chromosome 21 orthologues in the mouse. Nature 429, 586-590 (2002).
79. Kapranov, P. et al. Large-scale transcriptional activity in chromosomes 21 and 22. Science 296, 916-919 (2002).
80. O'Farrell, P. H. High resolution two-dimensional electrophoresis of proteins. J. Biol. Chem. 250, 4007-4021 (1975).
81. Weil, J. & Epstein, C. J. The effect of trisomy 21 on the patterns of polypeptide synthesis in human fibroblasts. Am. J. Hum. Genet. 31, 478-488 (1979).
82. Brown, W. T., Dutkowski, R. & Darlington, G. J. Localization and quantitation of human superoxide dismutase using computerized 2-D gel electrophoresis. Biochem. Biophys. Res. Comm. 102, 675-681 (1981).
83. Klose, J., Zeindl, E. & Sperling, K. Analysis of protein patterns in two-dimensional gels of cultured human cells with trisomy 21. Clin. Chem. 28, 987-992 (1982).
84. Patterson, D., Jones, C., Scoggin, C., Miller, Y. E. & Graw, S. Somatic cell approaches to Down's syndrome. Ann. NY Acad. Sci. 396, 69-81 (1982).
85. Van Keuren, M. L., Goldman, D. & Merril, C. R. Protein variations associated with Down's syndrome, chromosome 21, and Alzheimer's disease. Ann. N.Y. Acad. Sci. 396, 55-67 (1982).
86. Durr, E. et al. Direct proteomic mapping of the lung microvascular endothelial cell surface in vivo and in cell culture. Nature Biotechnol. 22, 985-992 (1994).
87. Unlu, M., Morgan, M. E. & Minden, J. S. Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis 18, 2071-2077 (1997).
88. Davisson, M. T. & Costa, A. C. S. in Advances in Neurochemistry Vol. 9 (ed. Popko, B.) 297-327 (Kluwer Academic/Plenum, New York, 1999).
89. McClure, H. M., Beiden, K. H., Pieper, W. A. & Jacobson, C. B. Autosomal trisomy in a chimpanzee: resemblance to Down's syndrome. Science 165, 1010-1012 (1969).
90. Watanabe, H. et al. DNA sequence and comparative analysis of chimpanzee chromosome 22. Nature 429, 382-388 (2004).
91. Shi, J. et al. Divergence of the genes on human chromosome 21 between human and other hominoids and variation of substitution rates among transcription units. Proc. Natl Acad. Sci. USA 100, 8331-8336 (2003).
92. Gropp, A., Giers, D. & Kolbus, U. Trisomy in the fetal backcross progeny of male and female metacentric heterozygotes of the mouse. I. Cytogenet. Cell Genet. 13, 511-535 (1974).
93. Epstein, C. J. in Trisomy 21 (Down Syndrome) Research Perspectives (eds de la Cruz, F. F. & Gerald, P. S.) 263-271 (Univ. Park Press, Baltimore, 1981).
94. Francke, U. & Taggart, R. T. Assignment of the gene for cytoplasmic superoxide dismutase (SOD1) to a region of chromosome 16 and of Hprt to a region of the X chromosome in the mouse. Proc. Natl Acad. Sci. USA 76, 5230-5233 (1979).
95. Polani, P., E. & Adinolfi, M. Chromosome 21 of man, 22 of the great apes and 16 of the mouse. Dev. Med. Child Neurol. 22, 223-233 (1980).
96. Miyabara, S., Gropp, A. & Winking, H. Trisomy 16 in the mouse fetus associated with generalized edema and cardiovascular and urinary tract anomalies. Teratology 25, 369-380 (1982).
97. Gearhart, J. M., Davisson, M. & Oster-Granite, M. L. Autosomal aneuploidy in mice: generation and developmental consequences. Brain Res. Bull. 16, 789-801 (1986).
98. Davisson, M. T., Schmidt, C. & Akeson E. C. in Molecular Genetics of Chromosome 21 and Down Syndrome (eds Patterson, D. & Epstein, C. J.) 263-280 (Wiley-Liss, New York, 1990).
99. Davisson, M. T. et al. in The Phenotypic Mapping of Down Syndrome and Other Aneuploid Conditions (ed. Epstein, C. J.) 117-133 (Wiley-Liss, New York, 1993).
100. Reeves, R. H. et al. A mouse model for Down syndrome exhibits learning and behaviour deficits. Nature Genet. 11, 177-183 (1995).
101. Holtzman, D. M. et al. Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome. Proc. Natl Acad. Sci. USA 93, 13333-13338 (1996).
102. Hyde, L. A. & Crnic, L. S. Age-related deficits in context discrimination learning in Ts65Dn mice that model Down syndrome and Alzheimer's disease. Behav. Neurosci. 115, 1239-1246 (2001).
103. Richtsmeier, J. T., Zumwalt, A., Carlson, E. J., Epstein, C. J. & Reeves, R. H. Craniofacial phenotypes in segmentally trisomic mouse models for Down syndrome. Am. J. Med. Genet. 107, 317-324 (2002).
104. Cataldo, A. M. et al. App gene dosage modulates endosomal abnormalities of Alzheimer's disease in a segmental trisomy 16 mouse model of Down syndrome. J. Neurosci. 23, 6788-6792 (2003).
105. Hampton, T. G., Stasko, M. R., Kale, A., Amende, I. & Costa, A. C. Gait dynamics in trisomic mice: quantitative neurological traits of Down syndrome. Physiol. Behav. 82, 381-389 (2004).
106. Olson, L. E. et al. Down syndrome mouse models Ts65Dn, Ts1Cje, and Ms1Cje/Ts65SDn exhibit variable severity of cerebellar phenotypes. Dev. Dyn. 230, 581-589 (2004).
107. Stasko, M. R. & Costa, A. C. S. Experimental parameters affecting the morris water maze performance of a mouse model of Down syndrome. Behav. Brain Res. 154, 1-17 (2004).
108. Kahlem, P. et al. Transcript level alterations reflect gene dosage effects across multiple tissues in a mouse model of Down syndrome. Genome Res. 14, 1258-1267 (2004).
109. Sago, H. et al. Ts1Cje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities. Proc. Natl Acad. Sci. USA 95, 6256-6261 (1998).
110. Sago, H. et al. Genetic dissection of region associated with behavioral abnormalities in mouse models for Down syndrome. Pediatr. Res. 48, 606-613 (2000).
111. Saran, N. G., Pletcher, M. T., Natale, J. E., Cheng, Y. & Reeves, R. H. Global disruption of the cerebellar transcriptome in a Down syndrome mouse model. Hum. Mol. Genet. 12, 2013-2019 (2003).
112. Lyle, R., Gehrig, C., Neergaard-Henrichsen, C., Deutsch, S. & Antonarakis, S. E. Gene expression from the aneuploid chromosome in a trisomy mouse model of Down syndrome. Genome Res. 14, 1268-1274 (2004).
113. Amano, K. et al. Dosage-dependent over-expresstan of genes in the trisomic region of Ts1Cje mouse model for Down syndrome. Hum. Mol. Genet. 13, 1333-1340 (2004).
114. Epstein, C. J. et al. Transgenic mice with increased Cu/Zn-superoxide dismutase activity: animal model of dosage effects in Down syndrome. Proc. Natl Acad. Sci. 84, 8044-8088 (1987).
115. Avraham, K. B., Sugarman, H., Rotshenker, S. & Groner, Y. Down's syndrome: morphological remodeling and increased complexity in the neuromuscular junction of transgenic CuZn-superoxide dismutase mice. J. Neurocytol. 20, 208-215 (1991).
116. Gahtan, E., Auerbach, J. M., Groner, Y. & Segal, M. Reversible impairment of long-term potentiation in transgenic Cu/Zn-SOD mice. Eur. J. Neurosci. 10, 538-544 (1998).
117. Harris-Cerruti, C. et al. Functional and morphological alterations in compound transgenic mice overexpreszing Cu/Zn superoxide dismutaze and amyloid precursor protein. Eur. J. Neurosci. 19, 1174-1190 (2004).
118. Busciglio J. et al. Altered metabolism of the amyloid β precursor protein is associated with mitochondrial dysfunction in Down's syndrome. Neuron 33, 677-688 (2002).
119. Peled-Kamar, M., Degani, H., Bendel, P., Margalit, R. & Groner, Y. Altered brain glucose metabolism in transgenic-PFKL mice with elevated L-phosphofructokinase: in vivo NMR studies. Brain Res. 810, 138-145 (1998).
120. Martinez de Lagrán, M. et al. Motor phenotypic alterations in TgDyrk1 a transgenic mice implicate DYRK1A in Down syndrome motor dysfunction. Neurobiol. Dis. 15, 132-142 (2004).
121. Chrast, R. et al. Mice trisomic for a bacterial artificial chromosome with the single-minded 2 gene (Sim2) show phenotypes similar to some of those present in the partial trisomy 16 mouse models of Down syndrome. Hum. Mol. Genet. 9, 1853-1864 (2000).
122. Bell, K., Shokrian, D., Potenzieri, C. & Whitaker-Azmitia, P. M. Harm avoidance, anxiety, and response to novelty in the adolescent S- t00β transgenic mouse: role of serotonin and relevance to Down syndrome. Neuropsychopharmacology 28, 1810-1816 (2003).
123. Wolvetang, E. J. et al. Overexpression of the chromosome 21 transcription factor Ets2 induces neuronal apoptosis. Neurobiol. Dis. 14, 349-356 (2003).
124. Horton, J. C. in Critical Thinking About Critical Periods (eds Bailey, D. B., Bruer, J. T., Symons, F. J. & Lichtman, J. W.) (Paul H. Brooks, Baltimore, 2001).
125. Pennington, B. F., Moon, J., Edgin, J., Stedron, J. & Nadel, L. The neuropsychology of Down syndrome: evidence for hippocampal dysfunction. Child. Dev. 74, 75-93 (2003).
126. Aylward, E. H. et al. MRI volumes of the hippocampus and amygdala in adults with Down's syndrome with and without dementia. Am. J. Psychiatry 156, 564-568 (1999).
127. Pinter, J. D. et al. Amygdala and hippocampal volumes in children with Down syndrome: a high-resolution MRI study. Neurology 56, 972-974 (2001).
128. Kleschevnikov, A. M. et al. Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome. J. Neurosci. 15, 8153-8160 (2004).
129. Hernandez, D., Mee, P. J., Martin, J. E., Tybulewicz, V. L. J. & Fisher, E. M. C. Transchromsomal mouse embryonic stem cell lines and chimeric mice that contain freely segregating segments of human chromosome 21. Hum. Mol. Genet. 8, 923-933 (1999).
130. Shinohara, T. et al. Mice containing a human chromosome 21 model behavioral impairment and cardiac anomalies of Down's syndrome. Hum. Mol. Genet. 10, 1163-1175 (2001).
131. Olson, L. E., Richtsmeier, J. T., Leszl, J. & Reeves, R. H. A chromosome 21 critical region does not cause specific Down syndrome phenotypes. Science 306, 687-690 (2004).
132. Gardiner, K., Davisson, M. T. & Crnic, L. S. Building protein interaction maps for Down's syndrome. Brief. Funct. Genomic Proteomic 3, 142-156 (2004).
133. Reynolds, T. M. Correspondence in J. Clin. Pathol. 54, 573-574 (2001).
134. Baker, D., Teklehaimanot, S., Hassan, R. & Guze, C. A look at a Hispanic and African American population in an urban prenatal diagnostic center: referral reasons, amniocentesis acceptance, and abnormalities detected. Genet. Med. 6, 211-218 (2004).
135. Elias, S. et al. Chorionic villus sampling for first-trimester prenatal diagnosis: Northwestern University program. Am. J. Obstet. Gynecol. 152, 204-213 (1985).
136. Merkatz, I. R., Nitowsky, H. M., Maori, J. N. & Johnson, W. E. An association between low maternal serum α-fetoprotein and fetal chromosomal abnormalities. Am. J. Obstet. Gynecol. 148, 886-894 (1984).
137. Christiansen, M. et al. Screening for Down's syndrome in early and late first and second trimester using six maternal serum markers. Clin. Genet. 65, 11-16 (2004).
138. Nicolaides, K. H., Azar, G., Byrne, D., Mansur, C. & Marks, K. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. BMJ 304, 867-869 (1992).
139. Bianchi, D. W. et al. Detection of fetal cells with 47,XY,+21 karyotype in maternal peripheral blood. Hum. Genet. 90, 368-370 (1992).
140. Glover, N. M. & Glover, S. J. Ethical and legal issues regarding selective abortion of fetuses with Down syndrome. Ment. Retard. 34, 207-214 (1996).
141. James, S. J. et al. Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase gene may be maternal risk factors for Down syndrome. Am. J. Clin. Nutr. 70, 495-501 (1999).
142. James, S. J. Maternal metabolic phenotype and risk of Down syndrome: beyond genetics. Am. J. Med. Genet. 127 (Part A), 1-4 (2004).
143. Pogribna, M. et al. Homocysteine metabolism in children with Down syndrome: in vitro modulation. Am. J. Hum. Genet. 69, 88-95 (2001).
144. Barkai, G., Arbuzova, S., Berkenstadt, M., Heifetz, S. & Cuckle, H. Frequency of Down's syndrome and neural-tube defects in the same family. Lancet 361, 1331-1335 (2003).
145. Hassold, T. & Hunt, P. To err (meiotically) is human: the genesis of human aneuploidy. Nature Rev. Genet. 2, 280-291 (2001).
146. Aagesen, L., Grinsted, J. & Mikkelsen, M. Advanced grandmaternal age on the mother's side - a risk of giving rise to trisomy 21. Ann. Hum. Genet. 48, 297-302 (1984).
147. Papp, Z., Varadi, E. & Szabo, Z. Grandmaternal age at birth of parents of children with trisomy. Hum. Genet. 39, 221-224 (1977).
148. Muller, H. J. Precision of genetic adaptation. Harvey Lect. 43, 165-229 (1948).